For more than four decades, we’ve been identifying, pursuing, and securing exceptional investment opportunities—especially those that are revolutionary, disruptive, and positioned to reshape their industries. Over the years, we’ve built a reputation for backing great companies at every stage of their growth.
We focus on delivering value through investment, strategic capital introductions, and the depth of experience that comes from participating in hundreds of deals. Our goal is always the same: to enhance each company’s ability to exceed its goals and achieve long‑term success.
With a proven ability to aggregate and deploy capital, along with hands‑on guidance in navigating the challenges that arise throughout the development cycle, we provide meaningful support that drives real impact.
Martin Sands is an accomplished investor and entrepreneur with over four decades of experience in finance, technology, and biotechnology. Having completed hundreds of deals / transactions, and worked with countless companies across every stage of company growth, from private early-stage seed investing to late stage pre IPO to all types of capital market transactions including IPOS / public offerings and restructurings and M&A. Marty has worked on both the buy side and sell side as a direct investor, manager, agent, principal, underwriter, advisor and consultant.
Over the past 15 years, he has focused on direct investments in revolutionary and transformative companies within the technology and biotechnology sectors. Along with these direct investments, he has partnered with prominent family offices and co-invested alongside leading venture funds, private equity groups and strategic corporate investors.
Martin Sand’s current focus spans technology, biotechnology, life sciences, medtech, artificial intelligence, software, cybersecurity, and quantum computing, where he collaborates with visionary leaders to advance disruptive and transformative ideas shaping the future.
Join our mailing list to be the first to know about new projects and news.